Skip to search formSkip to main contentSkip to account menu

CR002

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats
Abstract The efficacy of a novel Prunus domestica bark extract (Sitoprin, CR002) was investigated on testosterone propionate (TP… 
2015
2015
Efficacy of Novel Pygeum Extract (CR002) on Testosterone‐Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
The efficacy of a novel Prunus domestica extract (pygeum extract, CR002) was investigated on testosterone propionate (TP)‐induced… 
2008
2008
A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.
OBJECTIVE To investigate the safety, pharmacokinetics (PK), binding activity and immunogenicity of CR002, a human monoclonal… 
Highly Cited
2007
Highly Cited
2007
PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis.
BACKGROUND Arresting or regressing kidney scarring is of major clinical relevance. Platelet-derived growth factor D (PDGF-D) is… 
Highly Cited
2006
Highly Cited
2006
Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
Glomerular mesangial cell proliferation and/or matrix accumulation characterizes many progressive renal diseases. PDGF-D was… 
Highly Cited
2003
Highly Cited
2003
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
PDGF-B is of central importance in mesangioproliferative diseases. PDGF-D, a new PDGF isoform, like PDGF-B, signals through the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)